Imedex: Education is the Best Medicine®

Register for an upcoming conference!

Phone: +1 (678) 242 0906
registration@imedex.com

World Congress on Gastrointestinal Cancer: Asian Perspectives

28-29 August 2009

Taipei, Taiwan

The Westin Taipei

Who Should Attend

This educational activity is aimed at practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract.

Objectives

After successful completion of this course, attendees should be able to:

Discuss evolving multimodality treatment options for patients with esophageal cancer
Describe emerging treatment approaches for gastrointestinal stromal tumors
Evaluate the diagnostic tools and endoscopic techniques used to detect and manage early gastric cancer
Select the most appropriate therapeutic strategy for gastric cancer
Integrate advances in systemic and local therapies into clinical practice to treat hepatobiliary tumors
Summarize new and emerging treatment options for pancreatic cancer
Improve the outcomes of patients with localized colorectal disease by employing most favorable adjuvant therapy
Comment on the role of cytotoxic treatment regimens, angiogenesis inhibitors and EGFR inhibitors in advanced or metastatic colorectal cancer
Assess the clinical implications of using molecular markers as screening and prognostic tools for colorectal cancer
Review the most clinically relevant data recently presented regarding upper GI and colorectal cancer management
Comment on surgical techniques used to treat various gastrointestinal cancers

Chair:
Eric Van Cutsem, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Chair:
Yoon-Koo Kang, MD, PhD
Asan Medical Center
Seoul, Korea

Local Chair:
Ann-Lii Cheng, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Chul-Soo Ahn, MD
Asan Medical Center
Seoul, South Korea

Ian Chau, MD
Royal Marsden Hospital
Surrey, United Kingdom

Li-Tzong Chen, MD, PhD
National Health Research Institute
Taipei, Taiwain

Michael Choti, MD
The Sidney Kimmel Comprehensive
Cancer Center Baltimore at Johns Hopkins
Baltimore, Maryland

Jayesh Desai, MD, FRACP
Ludwig Institution for Cancer Research
Parkville, VIC, Australia

Tsann-Long Hwang, MD, FACS
Chang Gung Memorial Hospital
Taipei, Taiwan

Jeng-Kai Jiang, MD, PhD
Taipei Veterans General Hospital
Taipei, Taiwan

Paul B.S. Lai, MD
The Chinese University of Hong Kong
Shatin, Hong Kong

Brigette Ma MD
The Chinese University of Hong Kong
Shatin, Hong Kong

Ichiro Oda, MD
National Cancer Center Hospital
Tokyo, Japan

Jinsil Seong, MD, PhD
Yonsei University Medical College
Seoul, South Korea

Ming-Shiang Wu, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Ho-Young Song, MD
Asan Medical Center
Seoul, South Korea

Han-Kwang Yang, MD
Seoul National University Hospital
Seoul, South Korea

Kun-Huei Yeh, MD
National Taiwan University Hospital
Taipei, Taiwan

Simon C. Yu, MD
Chinese University of Hong Kong
Shatin, Hong Kong

Scientific Committee

Anthony TC Chan, MD, FRCP
Chinese University of Hong Kong
Shatin, Hong Kong

Alex Chang, MD, PhD
Johns Hopkins-NUH
International Medical Centre
Singapore, Singapore

Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg

Tae-Won Kim, MD
Asan Medical Center
Seoul, South Korea

Jin Li, MD, PhD
Fudan University Cancer Hospital
Shanghai, China

Atsushi Ohtsu, MD
National Cancer Center
Hospital East
Kashiwa, Japan

Virote Sriuranpong, MD, PhD
Chulalongkorn University
Bangkok, Thailand

John Zalcberg, MD
Peter MacCallum Cancer Center
Melbourne, Australia

Friday, 28 August 2009

8:00
Welcome and Introduction
Eric Van Cutsem, MD, PhD and Yoon-Koo Kang, MD, PhD

Session I: Epidemiology
8:05
Epidemiology and causes of GI cancer
Li-Tzong Chen, MD, PhD

Session II: Esophageal Cancer
Moderators: Virote Sriuranpong, MD, PhD

8:25
Surgery for esophageal cancer
Hui-Ping Liu, MD, FACS, FCCP

8:45
Multimodality treatment of esophageal cancer
Ian Chau, MD

9:05
Case discussion on the management of esophageal cancer
Ian Chau, MD, Virote Sriuranpong, MD, PhD and Hui-Ping Liu, MD, FACS, FCCP

Session III: Gastric Cancer
Moderator: Atsushi Ohtsu, MD, PhD and Ian Chau, MD

9:30
The role of expandable metallic stents in malignant gastroduodenal disease
Ho-Young Song, MD

9:50
Diagnosis and endoscopic management of early gastric cancer
Ichiro Oda, MD

10:10
Break

10:30
Surgical management of gastric cancer
Han-Kwang Yang, MD

10:50
Case discussion: Neo-adjuvant and adjuvant therapy for gastric cancer in the resected and unresected setting
Moderator: Yoon-Koo Kang, MD, PhD
Panel: Eric Van Cutsem, MD, PhD, Ian Chau, MD, Han-Kwang Yang, MD and Atsushi Ohtsu, MD, PhD

11:15
Chemotherapy of advanced gastric cancer
Kun-Huei Yeh

11:35
Selected abstract presentation on gastric cancer
Trastuzumab plus chemotherapy as first-line treatment for HER2-positive, inoperable advanced gastro-oesophageal and gastric cancer: Efficacy results from the ToGA trial
Yoon-Koo Kang, et al.
Yoon-Koo Kang, MD, PhD

12:00

12:15
Lunch Symposium
Supported by Taiho Pharmaceuticals Co., Ltd.

13:15
Break

13:30
Session IV: Highlights from 2009 in colorectal cancer management
Supported by sanofi-aventis

15:30
Break

Session V: Pancreatic Cancer
Moderator: Ann-Lii Cheng, MD, PhD

15:50
Surgical management of pancreatic cancer
Tsann-Long Hwang, MD, FACS

16:10
Pancreatic cancer treatments: Adjuvant therapies and metastatic disease
Li-Tzong Chen, MD, PhD

16:30
Case discussion on the management of bililary tract cancer
Li-Tzong Chen, MD, PhD and Tsann-Long Hwang, MD, FACS

16:50
Closing remarks

17:00
Adjourn

Saturday, 29 August 2009

8:30
Welcome and Introduction
Eric Van Cutsem, MD, PhD and Yoon-Koo Kang, MD, PhD

Session VI: Rare gastrointestinal malignancies
Moderators: John Zalcberg, MD and Mario Dicato, MD

8:35
Modern management of GIST tumors
Jayesh Desai, MD

8:55
Neuroendocrine tumors
John Zalcberg, MD

9:15
Case discussions on rare gastrointestinal malignancies
Yoon-Koo Kang, MD, PhD

Session VII: Localized Colorectal Cancer
Moderator: John Zalcberg, MD

9:40
Surgical management of rectal cancer

10:00
Adjuvant therapy for colorectal cancer
Tae-Won Kim, MD

10:20
Break and Poster Viewing

Session VIII: Advanced Colorectal Cance
Moderator: Alex Chang, MD

10:40
What is the optimal cytotoxic regimen in advanced colorectal cancer?
Li-Tzong Chen, MD, PhD

11:00
Angiogenesis inhibitors in metastatic colorectal cancer
Brigette Ma, MD

11:20
EGFR inhibitors in metastatic colorectal cancer
Eric Van Cutsem, MD, PhD

11:40
Predictive molecular markers in colorectal cancer
Mario Dicato, MD

12:00
What are the implications of molecular analysis of colorectal cancer in Asia?
Wei-Shu Wang, MD, PhD

12:20
Case discussion on colorectal cancer
Tae-Won Kim, MD

12:45
Session adjourns

13:00
Lunch Symposium
Supported by Pfizer Oncology

14:00 Break

Session IX: Hepatobiliary tumors
Moderator: Ann-Lii Cheng, MD and Jinsil Seong, MD

14:15
Surgical management of hepatocellular cancer and biliary cancers
Chul-Soo Ahn, MD

14:35
Non-surgical local treatment for hepatocellular carcinoma
Simon Yu, MD

14:55
Systemic treatment of hepatocellular carcinoma
Ann-Lii Cheng, MD, PhD

15:15
Radiation therapy for HCC
Jinsil Seong, MD

15:35
Case discussion on management of hepatocellular carcinoma
Alex Chang, MD

16:00 Break

Session X: Highlights from 2009 in upper GI cancer management
Moderator: Yoon-Koo Kang, MD, PhD

16:20
Molecular analysis of upper GI cancer
Ming-Shiang Wu, MD, PhD

16:40
Which targets are on the new horizons in gastric cancer
Atsushi Ohtsu, MD, PhD

17:00
Highlights from The Annual Oncology Meeting and World Congress on upper gastrointestinal cancer
Eric Van Cutsem, MD, PhD

17:20
Closing remarks

17:30
Adjourn

Abstract Submission Deadline Extended!

Participants interested in presenting data should submit abstracts online at www.imedex.com by 16 July 2009. Abstracts are subject to acceptance by the Scientific Committee.

Acceptance notifications and guidelines for poster presentation will be sent on 27 July 2009 Authors of accepted abstracts who have not registered will have until 14 August 2009 to do so at the rate of $225.00. After this date, abstracts without registered presenters will be disregarded. Submit your abstract online by going to www.imedex.com, selecting this Congress and following the instructions in the “Abstracts” section.

Abstract Guidelines

Follow the online instructions
Abstracts must be written in English
Accepted format: Word document format, 9 point Arial font, 500 word count limit
Use a concise title
List affiliations of author(s) as briefly as possible, with city, state and country
Place an asterisk (*) before the name of the presenting author
Use standard and well-accepted abbreviations
When using references, use standard and well-accepted formats
Abstract content should be single-spaced, typed in lower case and contain:
- Purpose of the study
- Summarized description of the project
- Results and conclusion

Submission Deadline
16 July 2009

Registration Fees Discounted .............................................$ 225 USD
If payment received by 12 June 2009

Regular..............................................................................$ 275 USD
If payment received by 20 August 2009

Full/Onsite*.......................................................................$ 325 USD
If payment received after 20 August 2009

Nurses/Residents/Students*...............................................$ 50 USD
*proof of eligibility must accompany registration and will be verified

Important Dates
Discounted Registration Deadline
Tuesday, 12 June 2009

Abstract Notifications Mailed
Tuesday, 14 July 2009

Abstract Presenter Registration Deadline
Tuesday, 28 July 2009

Abstract Submission Deadline
Tuesday, 28 July 2009

Regular Registration
Thursday, 20 August 2009

Presentation Dates
Friday, 28 August 2009

To Register: You may register online by 20 August 2009 at www.imedex.com, by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than 20 August 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 20 August 2009. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 20 August 2009.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change

The Westin Taipei
133 Nanking East Road, Section 3
Taipei 104, Taiwan
Tel.: +886 2 8770 6565
Fax: +886 2 8770 6555

The Westin Taipei provides a unique cultural touch and an oasis for rejuvenation in the financial, commercial and entertainment district of Taipei City’s Nanking East Road. The hotel is a mere 40 minutes drive from Tao Yuan International Airport and convenient to the MRT.

Ideal for both business and leisure travelers, the Westin Taipei is conveniently located near major shopping centers and global corporate enterprises. The hotel is also close to Taipei 101 – the tallest building in the world – and not far from the National Palace Museum with its exquisite collections of ancient treasures, as well as night markets bustling with activity.

For the convenience of attendees, a limited number of rooms have been reserved until 1 August 2009 at a discounted rate of NT $7,600 single/double occupancy, plus service charge of 10% and tax, currently at 5% including breakfast for one person. This rate is not guaranteed outside the conference dates or after 1 August 2009.

To reserve your room please contact the Westin Taipei reservations department at (886) 2 8770 6565 or visit the hotel’s website at http://www.starwoodmeeting.com/Book/GI2009 OR http://www.starwoodmeeting.com/StarGroupsWeb/res?id=0905207742&key=83698. To receive the group rate, callers must identify themselves as being with the World Congress on Gastrointestinal Cancer: Asian Perspectives group. Reservation requests received after 1 August 2009 may not be guaranteed the group rate.

The Registration and Information Desk will be staffed:
Friday, 28 August 2009: 7:30 – 17:30
Saturday, 29 August 2009: 8:00 – 16:30

Dear Colleague

It is our pleasure to invite you to attend the 3rd Conference –World Congress on Gastrointestinal Cancer: Asian Perspectives, August 28-29, 2009 in Taipai, Taiwan. Guided by an expert international faculty, this two-day scientific meeting will provide a detailed overview of the state-of-the-art in management of gastrointestinal cancer, with a spotlight on current trends and controversies and significant developments which may lead to improved results.

The Congress is intended to specifically address the needs of the Asian patient population. Attendees will update their knowledge in the field, confirm their current practices and receive valuable take-home information. New this year, we will review clinical cases to evaluate treatment alternatives, and our multi-disciplinary approach will highlight surgical perspectives.

Poster presentations provide opportunities for researchers to interact with colleagues and share their endeavors with the healthcare community. We invite you to participate this year by submitting an abstract of your work to be considered for presentation.

We know you will find the World Congress on Gastrointestinal Cancer: Asian Perspectives to be a valuable, world-class educational event, and we hope to see you there! Sincerely, Chairs: Eric Van Cutsem, MD, PhD Yoon-Koo Kang, MD, PhD Local Chair: Ann-Lii Cheng, MD, PhD

Sincerely,

Chairs:
Eric Van Cutsem, MD, PhD
Yoon-Koo Kang, MD, PhD

Local Chair:
Ann-Lii Cheng, MD, PhD

ORGANIZER

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.

In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.

The following companies have provided an educational grant in support of this Congress:

SILVER

Wyeth

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.

Information coming soon.